Advertisement

Citation tools

Nieborowska-Skorska, Margaret et al "Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms." Blood (2017): blood-2017-05-784942. Web. 24 Nov. 2017.